Literatur
-
1
Nides M A, Tashkin D P, Simmons M S, Wise R A, Li V C, Rand C S.
Improving inhaler adherence in a clinical trial through the use of nebulizer chronolog.
Chest.
1993;
104
501-507
-
2
Brueckner J W, Marshik P, Sherman J, Hendeles L.
Reliability of the medtrac MDI chronolog.
J Allergy Clin Immunol.
1997;
100
488-491
-
3
Simmons M S, Nides M A, Kleerup E C, Chapman K R, Milgrom H, Rand C S, Spector S L, Tashkin D P.
Validation of the doser, a new device for monitoring metered-dose inhaler use.
J Allergy Clin Immunol.
1998;
102
409-413
-
4 Hasford J, Behrend C, Sangha O. Vergleichende Analyse und Bewertung von Methoden zur Erfassung der Compliance. In: Petermann F (Hrsg.). Compliance und Selbstmanagement Göttingen: Hogrefe 1998: 21-44
-
5
Tashkin D P, Rand C, Nides M, Simmons M, Wise R, Coulson A H, Li V, Gong H.
A nebulizer chronolog to monitor compliance with inhaler use.
Am J Med.
1991;
91 (suppl)
33-36
-
6
Nides M A, Tashkin D P, Simmons M S, Wise R A, Li V C, Rand C S.
Improving inhaler adherence in a clinical trial through the use of nebulizer chronolog.
Chest.
1993;
104
501-507
-
7
Yeung M, O'Connor S A, Parry D T, Cochrane G M.
Compliance with prescribed drug therapy in asthma.
Respir Med.
1994;
88
31-35
-
8
Rand C S.
Objective measurement of metered-dose inhaler use. Ethical considerations.
Am J Respir Crit Care Med.
1994;
149
289-290
-
9
Simmons M S, Nides M A, Rand C S, Wise R A, Tashkin D P.
Trends in Compliance with bronchiodilator inhaler use between follow-up visits in a clinical trial.
Chest.
1996;
109
963-968
-
10
Klocke R A.
Ethics of monitoring patient adherence. An evolving dilemma.
Am J Respir Crit Care Med.
1994;
149
286
-
11
Rand C S.
Objective measurement of metered-dose inhaler use. Ethical considerations.
Am J Respir Crit Care Med.
1994;
149
289-290
-
12
Rand C S, Wise R A, Nides M, Simmons M S, Bleeker E R, Kusek J W, Li C, Tashkin D P, Levine R J.
Metered-dose inhaler adherence in a clinical trial.
Am Rev Respir Dis.
1992;
146
1559-1564
-
13
Levine R J.
Monitoring for adherence: ethical considerations.
Am J Respir Crit Care Med.
1994;
149
287-288
-
14
Rand C S.
Objective measurement of metered-dose inhaler use. Ethical considerations.
Am J Respir Crit Care Med.
1994;
149
289-290
-
15
Cochrane G M.
Compliance and outcomes in patients with asthma.
Drugs.
1996;
52
12-19
-
16
Levine R J.
Monitoring fo adherence: ethical considerations.
Am J Respir Crit Care Med.
1994;
149
287-288
-
17
Cochrane G M.
Compliance and outcomes in patients with asthma.
Drugs.
1996;
52
12-19
-
18
Rand C S.
Objective measurement of metered-dose inhaler use. Ethical considerations.
Am J Respir Crit Care Med.
1994;
149
289-290
-
19
Fischer J.
Compliance und Ethik - Gibt es ein Recht auf Non-Compliance?.
Man Care.
2000;
14-17
-
20 Hasford J. Klinische Studien - Wo sind die Fehlerquellen? Vortrag auf dem 41. Kongress der Deutschen Gesellschaft für Pneumologie 1.-3. 3. 2000 in Hamburg.
-
21
Dinges D F, Kribbs N B, Schwartz A R, Smith P L, Pack A I.
Objective measurement of nasal continuous positive airway pressure use. Ethical considerations.
Am J Respir Crit Care Med.
1994;
149
291-292
-
22
Worstell M.
Asthma: individual patient perspective and current unmet needs.
Clin Exp Allergy.
2000;
30 (suppl)
11-15
1 „Verbreitung der Non-Compliance bei Asthma-Patienten: Aktueller Forschungsstand und methodologische Probleme”
3 Der Beitrag enthält Auszüge aus der Habilitationsschrift des Zweitautors
Dr S Mühlig
ZRF
Universität Bremen
Grazer Straße 6
28359 Bremen
Email: E-mail: muehlig@uni-bremen.de
